Kingdon Capital Management, L.L.C. Athenex, Inc. Transaction History

Kingdon Capital Management, L.L.C.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$3.71 - $5.13 $5.74 Million - $7.94 Million	-1,547,879 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$4.08 - $14.75 $9.85 Million - $35.6 Million	-2,413,081 Reduced 60.92%	1,547,879 $6.66 Million
Q4 2020 Feb 16, 2021	BUY	$11.06 - $14.01 $1.11 Million - $1.4 Million	100,000 Added 2.59%	3,960,960 $43.8 Million
Q3 2020 Nov 16, 2020	BUY	$10.26 - $14.55 $1.49 Million - $2.11 Million	145,000 Added 3.9%	3,860,960 $46.7 Million
Q1 2020 May 15, 2020	BUY	$5.71 - $15.85 $14.7 Million - $40.7 Million	2,565,960 Added 223.13%	3,715,960 $28.8 Million
Q4 2019 Feb 14, 2020	BUY	$9.6 - $17.75 $5.89 Million - $10.9 Million	613,627 Added 114.4%	1,150,000 $17.6 Million
Q3 2019 Nov 14, 2019	SELL	$12.16 - $21.0 $383,793 - $662,802	-31,562 Reduced 5.56%	536,373 $6.53 Million
Q2 2019 Aug 14, 2019	BUY	$9.44 - $19.8 $279,839 - $586,951	29,644 Added 5.51%	567,935 $11.2 Million
Q1 2019 May 14, 2019	BUY	$11.11 - $13.49 $1.53 Million - $1.85 Million	137,368 Added 34.26%	538,291 $6.59 Million
Q4 2018 Feb 14, 2019	BUY	$10.24 - $15.49 $4.11 Million - $6.21 Million	400,923 New	400,923 $5.09 Million

1.46M

Ticker ATNX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 156,790,000
Market Cap $1.57M
Description
Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The company's Orascovery product candidates include Oral paclitaxel and encequidar,...

Get notified when there are updates to the investment portfolio of Kingdon Capital Management, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Kingdon Capital Management, L.L.C. with notifications on news.